Dr. McKee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
245 Main Street
Cambridge, MA 02142Phone+1 202-655-8185- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2003 - 2006
- Tufts Medical CenterResidency, Pediatrics, 2000 - 2003
- Tulane University School of MedicineClass of 2000
Certifications & Licensure
- MD State Medical License 2003 - 2025
Awards, Honors, & Recognition
- National Cancer Institute Director’s Innovation Award/Career Development Award National Cancer Institute, NIH, 2008
Publications & Presentations
PubMed
- 152 citationsFDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum‐Co...Erin Larkins, Gideon M. Blumenthal, Weishi Yuan, Kun He, Rajeshwari Sridhara
The Oncologist. 2017-07-01 - 47 citationsFDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Ad...Gwynn Ison, Julia A. Beaver, W. David McGuinn, Todd R. Palmby, Jeannette Dinin
Clinical Cancer Research. 2016-09-15 - 35 citationsFDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple MyelomaElizabeth Dianne Pulte, Andrew Dmytrijuk, Lei Nie, Kirsten B. Goldberg, Amy E. McKee
The Oncologist. 2018-06-01
Journal Articles
- FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy.Kim G, Ison G, McKee AE, Zhang H, Tang S, Gwise T, Sridhara R, Lee E, Tzou A, Philip R, Chiu HJ, Ricks TK, Palmby T, Russell AM, Ladouceur G, Pfuma E, Li H, Zhao L, Li..., Clin Cancer Res, 2015
- NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.Venook AP, Arcila ME, Benson AB 3rd, Berry DA, Camidge DR, Carlson RW, Choueiri TK, Guild V, Kalemkerian GP, Kurzrock R, Lovly CM, McKee AE, Morgan RJ, Olszanski AJ, R..., J Natl Compr Canc Netw, 2014
- PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling.Weldon CB, McKee A, Collins-Burow BM, Melnik LI, Scandurro AB, McLachlan JA, Burow ME, Beckman BS., Int J Oncol, 2005
- Join now to see all
Abstracts/Posters
- Unlike Other Cancers, Neuroblastoma Contains a High Frequency of Tumor-initiating Cells with Stem Cell-Like Behavior.Amy E. McKee, Loen M. Hansford, David Venzon, David R. Kaplan, Carol J. Thiele., Advances in Neuroblastoma Research Meeting, 2008
- BDNF/TrkB pathway upregulates PTHrP in neuroblastoma.Amy E. McKee, Kelly Martin, Ana Markovic, Braden T. Greer, Jun S. Wei, Qing R. Chen, Javed Khan, and Carol J. Thiele., American Association of Cancer Research Annual Meeting, 2006
- PTHrP, a Mediator of Bone Metastasis, Is a Target of TrkB but Not TrkA in Neuroblastoma.Amy E McKee, Kelly Martin, Katsuya Nakamura, Braden Greer, Jun Wei, Javed Khan, Carol J Thiele., Advances in Neuroblastoma Research, 2006
- Join now to see all
Press Mentions
- Parexel Introduces Expert Series - New Medicines, Novel InsightsFebruary 28th, 2023
- Medicenna Therapeutics to Present at Upcoming March Investor ConferencesDecember 9th, 2020
- Parexel Hiring Spree Continues as It Nabs China, U.S. And Europe Regulator AlumniJuly 27th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: